Filling the need for trusted information on national health issues…

Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

Malaria Vaccine Shows Some Protection For One Year In Clinical Trial

New York Times: A Malaria Vaccine Has Some Success in Testing “An experimental malaria vaccine tested in varying doses provided 55 percent protection for one year to a few volunteers, a study released Monday said…” (McNeil, 5/9). Science Speaks: Malaria vaccine candidate shows longer protection, promise, direction of next steps…

Gates Foundation Awards $38M To Takeda Pharmaceuticals To Develop Low-Cost Polio Vaccine

Reuters: Gates Foundation backs Takeda polio vaccine with $38 million grant “Japan’s Takeda Pharmaceuticals is to get $38 million from the Bill & Melinda Gates Foundation to develop a crucial, low-cost polio vaccine for use in developing countries. … Chris Elias, the Gates Foundation’s head of global development, said the…

Nations Ponder Financial Incentives To Spur New Antibiotic Research, Development

The Lancet: Countries mull over incentives for developing antibiotics “The prospect of slipping into a deadly, post-antibiotic era is prompting countries across the world to work out when and what they are willing to pay drug companies to develop desperately needed antibiotics. Governments have commissioned academics, economists, business analysts, and…

STAT Profiles Wellcome Trust Director Jeremy Farrar

STAT: With billions in the bank, a ‘visionary’ doctor tries to change the world “…At a time when government funding for public health research is shrinking across much of the world, and epidemics wreak havoc with what seems like increasing frequency, [Wellcome Trust Director Jeremy] Farrar stands to make a…

NIH Official, Florida Governor Urge Congress To Approve Emergency Zika Funding

Bloomberg BNA: Fauci: Zika Funding Lack Hurts Other Health Efforts “It’ll be ‘very destructive’ to other public health efforts if Congress doesn’t provide the Zika funds requested by the Obama administration, the head of the NIH’s infectious disease programs said May 3. Anthony S. Fauci, director of the National Institute…

Infection With Wolbachia Bacteria Blocks Mosquitoes From Transmitting Zika, Study Shows

New York Times: Bacteria-Infected Mosquitoes Could Slow Spread of Zika Virus “…Ever since the Zika outbreak began in Brazil last year, scientists have suspected that Wolbachia might protect mosquitoes from the virus. Now, researchers have confirmed this hunch, providing the first solid evidence that releasing Wolbachia-infected mosquitoes into the wild…

MSF Report Examines Gaps In, Offers Policy Recommendations For Medical R&D

Center for Global Health Policy’s “Science Speaks”: With biomedical research driven by profit rather than need, MSF examines why innovation fails to address world’s biggest health problems Antigone Barton, senior editor and writer of “Science Speaks,” discusses a recently released report by Médecins Sans Frontières (MSF), “examining the impacts of…

USDA To Provide $6M For Research Into Antimicrobial Resistance

CIDRAP News: USDA offers $6 million for antimicrobial resistance research “The U.S. Department of Agriculture (USDA) [Monday] announced the availability of $6 million for research on antimicrobial resistance in agriculture, including how resistance develops and spreads and how to combat it…” (Roos, 5/3).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.